X-spine Systems, Inc. is a spinal implant company that develops spinal implants and instrumentation for the treatment of spinal disease worldwide. The company offers cervical products, such as cervical plating systems, cervical allograft interbody spacers, cervical interbody spacer systems, cervical plasma coated PEEK, cervical integrated fusion systems, and cervical plates and screws; cervico-thoracic solutions, including spinal fixation systems; thoracolumbar solutions, such as interspinous fusion systems, anterior lumbar buttress plating solutions, plasma coated PEEK implants, PEEK lumbar systems, spinal facet screw systems, pedicle screw systems, lumbar integrated fusion systems, pedicle...
452 Alexandersville Road
Miamisburg, OH 45342
Founded in 2003
Xtant™ Medical Receives Clearance of Expanded Indication for Ilium Fixation and Deformity
Dec 1 15
Xtant Medical Holdings, Inc. announced that its wholly owned subsidiary, X-spine Systems, Inc. received FDA clearance of expanded indications to include ilium fixation as well as extended length screws for the FortexÂ® and the Xpressâ„¢ 2 Pedicle Screw System. The extended length screws are compatible with X-spine's current Fortex and Xpress instrument systems, offering a comprehensive pedicle screw portfolio. These dual lead, non-cannulated screws are indicated for use in posterior, non-cervical, T1-S2/Ilium pedicle spinal fixation. They are intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of degenerative spondylolisthesis, fracture, dislocation, scoliosis, kyphosis, spinal tumors, and failed previous fusion.
X-Spine Systems, Inc. Receives FDA clearance of the Aranax Cervical Plate
Sep 9 15
Xtant Medical Holdings, Inc. announced that its wholly owned subsidiary, X-spine Systems, received FDA clearance of the Aranax Cervical Plate. The Aranax System represents the latest generation of anterior cervical fixation with an enhanced locking mechanism, low profile features, increased screw angulation and intuitive instrumentation. Indications for the Aranax implant include fusion on one to four contiguous levels of the cervical spine, through an anterior approach (C1-C7 inclusive). The sterile packaging will reduce facility processing costs for hospitals and improve procedure planning.
X-Spine Systems, Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2015
Aug 14 15
X-spine Systems, Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2015. For the quarter, revenue was $11,729,509 against $12,793,067 for the same period of last year. Income from operations was $1,124,496 against $2,410,541 for the same period of last year. Income before city income tax expense was $1,037,711 against $2,260,541 for the same period of last year. Net income was $1,051,500 against $2,215,331 for the same period of last year.
For the six months, revenue was $23,954,756 against $20,706,023 for the same period of last year. Income from operations was $1,967,625 against $2,937,383 for the same period of last year. Income before city income tax expense was $1,801,166 against $2,637,383 for the same period of last year. Net income was $1,790,023 against $2,559,913 for the same period of last year. Net cash provided by operating activities was $1,735,805 against $2,626,223 for the same period of last year. Patent and trademark purchases was $81,716 against $104,189 for the same period of last year. Purchase property and equipment was $1,191,712 against $2,233,598 for the same period of last year.